ATLASGrace Therapeutics (GRCE) earnings date: Nov 12, 2026
Grace Therapeutics (GRCE) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 12, 2026.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on GRCE
| Last price | $1.89 (-2.8%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.3% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Grace Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Grace Therapeutics reports on Nov 12, 2026. One email the day before, with ATLAS’s read on Grace Therapeutics. You can switch it off at any time.
Alert me before GRCE reportsFree to start. Creating an account takes under a minute.
Notify me when Grace Therapeutics reports
Track GRCE free Add Grace Therapeutics to a free ATLAS watchlist and see its next report date in one place.
GRCE earnings at a glance
| Next report (confirmed) | Thu, Nov 12, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| Last report | Aug 13, 2026 · In line |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | +15.4% |
| Average move around a report | ±2.4% (last 5) |
| Sector | Healthcare · Biotechnology |
Grace Therapeutics earnings history: last 5 reports
Grace Therapeutics last reported on Aug 13, 2026: EPS of -$0.18 against an estimate of -$0.18 (0.0% surprise), in line with the estimate.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 13, 2026 | -$0.18 | -$0.18 | 0.0% | In line | +2.9% |
| Jul 18, 2026 | $0.39 | $0.38 | -2.6% | Miss | -1.6% |
| Jun 18, 2026 | -$0.20 | -$0.08 | +60.0% | Beat | +1.8% |
| May 12, 2026 | $0.68 | $0.70 | +2.9% | Beat | -4.3% |
| Feb 27, 2026 | $0.18 | $0.21 | +16.7% | Beat | -1.2% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for GRCE
See the fair value, the probability range and the earnings history of Grace Therapeutics on its ATLAS page.
Grace Therapeutics (GRCE) stock analysisPlans from €3.99 a month.
Grace Therapeutics earnings: frequently asked questions
When does Grace Therapeutics (GRCE) report earnings?
Grace Therapeutics is scheduled to report on Thursday, November 12, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does GRCE beat earnings estimates?
Of its last 5 reports with a recorded result, Grace Therapeutics beat the EPS estimate 3 times; the average surprise was +15.4%. Past results do not predict the next one.
How much does GRCE move around earnings?
Over its last 5 reports the stock moved an average of 2.4% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did Grace Therapeutics beat earnings estimates last quarter?
Grace Therapeutics last reported on Aug 13, 2026: EPS of -$0.18 against an estimate of -$0.18 (0.0% surprise), in line with the estimate.
How much does GRCE usually move in a day?
On a normal trading day the ATLAS model puts GRCE’s one-day range at about ±3.3%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 12, 2026
Educational information, not investment advice. Disclaimer